Skip to main content
OpenTrials

Clinical trial condition

Rhabdomyosarcoma

Explore clinical trials studying Rhabdomyosarcoma. Study availability and eligibility vary by location and protocol.

104 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Rhabdomyosarcoma trial results

Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

Collecting and Storing Tissue From Young Patients With Cancer

NCT00898755

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Central Nervous System Neoplasm, +47 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

NCT05697198

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +68 more
Locations
  • Clinical Site Fort Payne, Alabama, United States
  • Clinical Site Orange City, Florida, United States
  • Clinical Site Stuart, Florida, United States
  • Clinical Site Dublin, Georgia, United States
View Trial Details
Completed

Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)

NCT03220035

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +67 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 116 locations
View Trial Details
Completed

A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

NCT02509598

Conditions
Melanoma, Myosarcoma, Neoplasms, +14 more
Locations
  • Nemours Children's Specialty Care Jacksonville, Florida, United States
  • Nemours Children's Hopsital Orlando, Florida, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Nationwide Children's Hospital Columbus, Ohio, United States
View Trial Details
Completed

A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors

NCT05093322

Conditions
Ewing Sarcoma, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Childrens Hospital Orange County Orange, California, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
View Trial Details

Related conditions